Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
1.210
+0.020 (1.68%)
Nov 21, 2024, 11:49 AM EST - Market open
Biodesix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 65.56 | 49.09 | 38.21 | 54.51 | 45.56 | 24.55 | Upgrade
|
| Revenue Growth (YoY) | 48.92% | 28.46% | -29.89% | 19.64% | 85.55% | 20.16% | Upgrade
|
| Cost of Revenue | 14.61 | 13.01 | 14.15 | 30.52 | 22 | 6.07 | Upgrade
|
| Gross Profit | 50.96 | 36.08 | 24.06 | 23.99 | 23.56 | 18.48 | Upgrade
|
| Selling, General & Admin | 76.48 | 67.39 | 61.46 | 50.52 | 34.86 | 30.64 | Upgrade
|
| Research & Development | 9.03 | 9.99 | 13.1 | 12.79 | 10.82 | 10.47 | Upgrade
|
| Operating Expenses | 85.52 | 77.38 | 74.56 | 63.31 | 45.68 | 41.11 | Upgrade
|
| Operating Income | -34.56 | -41.3 | -50.51 | -39.32 | -22.12 | -22.63 | Upgrade
|
| Interest Expense | -8.84 | -9.54 | -8.07 | -4.51 | -7.6 | -3.01 | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | -1.27 | 0.19 | -0.01 | -0.81 | -1.03 | Upgrade
|
| EBT Excluding Unusual Items | -43.41 | -52.1 | -58.39 | -43.84 | -30.53 | -26.61 | Upgrade
|
| Asset Writedown | -0.16 | -0.04 | -0.08 | - | - | - | Upgrade
|
| Other Unusual Items | -0.25 | - | -6.98 | 0.68 | -0.82 | -4.11 | Upgrade
|
| Pretax Income | -43.82 | -52.15 | -65.45 | -43.16 | -31.35 | -30.73 | Upgrade
|
| Net Income | -43.82 | -52.15 | -65.45 | -43.16 | -31.35 | -30.73 | Upgrade
|
| Net Income to Common | -43.82 | -52.15 | -65.45 | -43.16 | -31.35 | -30.73 | Upgrade
|
| Shares Outstanding (Basic) | 116 | 82 | 42 | 27 | 5 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 116 | 82 | 42 | 27 | 5 | 0 | Upgrade
|
| Shares Change (YoY) | 57.83% | 95.03% | 53.86% | 465.63% | 1899.17% | 21.14% | Upgrade
|
| EPS (Basic) | -0.38 | -0.64 | -1.55 | -1.58 | -6.48 | -126.97 | Upgrade
|
| EPS (Diluted) | -0.38 | -0.64 | -1.55 | -1.58 | -6.48 | -126.97 | Upgrade
|
| Free Cash Flow | -62.21 | -45.79 | -48.27 | -30.46 | -24.06 | -23.49 | Upgrade
|
| Free Cash Flow Per Share | -0.54 | -0.56 | -1.15 | -1.11 | -4.97 | -97.07 | Upgrade
|
| Gross Margin | 77.72% | 73.50% | 62.96% | 44.01% | 51.71% | 75.26% | Upgrade
|
| Operating Margin | -52.71% | -84.13% | -132.17% | -72.14% | -48.55% | -92.16% | Upgrade
|
| Profit Margin | -66.84% | -106.23% | -171.27% | -79.18% | -68.81% | -125.15% | Upgrade
|
| Free Cash Flow Margin | -94.89% | -93.28% | -126.32% | -55.89% | -52.82% | -95.68% | Upgrade
|
| EBITDA | -29.26 | -37.97 | -46.91 | -36.14 | -19.21 | -19.83 | Upgrade
|
| EBITDA Margin | -44.63% | -77.35% | -122.76% | -66.30% | -42.17% | -80.78% | Upgrade
|
| D&A For EBITDA | 5.3 | 3.33 | 3.6 | 3.18 | 2.9 | 2.79 | Upgrade
|
| EBIT | -34.56 | -41.3 | -50.51 | -39.32 | -22.12 | -22.63 | Upgrade
|
| EBIT Margin | -52.71% | -84.13% | -132.17% | -72.14% | -48.55% | -92.16% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.